Search results
Results From The WOW.Com Content Network
The concept of grading of the tumors of the central nervous system, agreeing for such the regulation of the "progressiveness" of these neoplasias (from benign and localized tumors to malignant and infiltrating tumors), dates back to 1926 and was introduced by P. Bailey and H. Cushing, in the elaboration of what turned out the first systematic classification of gliomas.
Adenocarcinoma of the lung. A gross pathological specimen of a pulmonary adenocarcinoma, removed in a lobectomy. Adenocarcinoma of the lung is the most common type of lung cancer, and like other forms of lung cancer, it is characterized by distinct cellular and molecular features. [ 1] It is classified as one of several non-small cell lung ...
The International Classification of Diseases for Oncology ( ICD-O) is a domain-specific extension of the International Statistical Classification of Diseases and Related Health Problems for tumor diseases. This classification is widely used by cancer registries . It is currently in its third revision (ICD-O-3).
Detail of a CT thorax showing a mixed solid and ground glass lung lesion consistent with an adenocarcinoma of the lung. Specialty. Oncology . Adenocarcinoma in situ(AIS) of the lung—previously included in the category of "bronchioloalveolar carcinoma" (BAC)—is a subtype of lung adenocarcinoma. It tends to arise in the distalbronchiolesor ...
Oncology. Histopathologic image from ductal cell carcinoma in situ (DCIS) of breast (hematoxylin and eosin stain) Ductal carcinoma in situ ( DCIS ), also known as intraductal carcinoma, is a pre-cancerous or non-invasive cancerous lesion of the breast. [ 1][ 2] DCIS is classified as Stage 0. [ 3] It rarely produces symptoms or a breast lump ...
The International Classification of Diseases, Clinical Modification (ICD-9-CM) was an adaptation created by the US National Center for Health Statistics (NCHS) and used in assigning diagnostic and procedure codes associated with inpatient, outpatient, and physician office utilization in the United States. The ICD-9-CM is based on the ICD-9 but ...
The more aggressive forms of disease require treatment with chemotherapy, radiotherapy, immunotherapy and—in some cases—a bone marrow transplant. The use of rituximab has been established for the treatment of B-cell–derived hematologic malignancies, including follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). [7]
Oncology. Non-small-cell lung cancer ( NSCLC ), or non-small-cell lung carcinoma, is any type of epithelial lung cancer other than small-cell lung cancer (SCLC). NSCLC accounts for about 85% of all lung cancers. [ 1][ 2][ 3] As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small-cell carcinoma.